Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Care Coordination, Equity Can Eliminate Disparities for Nonwhite Patients with DLBCL

Publish date:: December 8, 2019

Key clinical point: A care coordination program can level the playing field for nonwhite patients with diffuse large B-cell lymphoma (DLBCL).

Major finding: Overall survival for patients with relapsed/refractory disease was 74% for whites and 81% for nonwhites.

Study details: Retrospective review of data on 155 white and 41 nonwhite patients with de novo DLBCL.

Disclosures: The study was internally funded. Dr. Ghosh reported consulting fees, research funding, speakers bureau activity, and/or honoraria from multiple companies.

Citation:

Hu B et al. ASH 2019. Abstract 425.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in DLBCL

Synthetic lethality: Triple combination is a viable strategy for B-cell malignancies,

Bispecific antibody odronextamab demonstrates durable complete responses in refractory NHL,

Survey quantifies COVID-19’s impact on oncology,

Sarcopenia is a predictor of overall survival in DLBCL patients,

Mutation tied to central nervous system collapse in DLBCL,